Media centre

Press releases 2006

Almus® announces Sumaptriptan off-patent launch
15 May 2006

Almus Pharmaceuticals announces the off-patent launch of Sumaptriptan 50mg and 100mg on 15 May 2006. Almus® Sumatriptan offers pharmacists and patients a unique patient safety benefit as the only off-patent product to feature individual tablets and markings identified with full colour illustrations on each pack.

"Sumatriptan is part of a significant new development phase for Almus Pharmaceuticals. With the recent launch of several new and high profile products including Omeprazole and Diclofenac as well as this off-patent launch, Almus® continues to demonstrate fundemental growth in its range and to lead the generics market with a superior patient safe pack design", commented Tony Foreman, Group Director of Commercial Activities, Alliance UniChem and CEO of Almus Pharmaceuticals.

For more information on Sumatriptan, the Almus® range or to receive a copy of the new Almus® product guide, please call: 0800 633 5950.